Loading…
Sun Pharma Advanced Research Company (SPARC)₹210.80+6.99%Pharmaceuticals
At the end of the Jun 2026 quarter, Sun Pharma Advanced Research Company's shareholders were: promoters 65.74%, FIIs 3.93%, DIIs 0.09%, public 30.24%. Promoter holding is up 0.01 percentage points from 65.73% a quarter earlier. FII holding is up 2.45 percentage points from 1.48% a year earlier. 0.00% of promoter shares were pledged. It had 1,41,909 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 65.74% | 65.74% | 65.74% | 65.74% | 65.74% | 65.74% | 65.74% | 65.73% | 65.73% | 65.73% | 65.73% | 65.74% |
| FIIs | 3.70% | 3.33% | 3.27% | 2.66% | 2.17% | 2.25% | 1.46% | 1.48% | 1.77% | 2.06% | 2.06% | 3.93% |
| DIIs | 0.64% | 0.66% | 0.66% | 0.17% | 0.21% | 0.63% | 1.12% | 0.96% | 1.04% | 0.77% | 0.87% | 0.09% |
| Public | 29.92% | 30.27% | 30.33% | 31.43% | 31.88% | 31.38% | 31.68% | 31.83% | 31.46% | 31.44% | 31.34% | 30.24% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,01,399 | 1,03,955 | 1,02,708 | 1,25,142 | 1,28,162 | 1,30,990 | 1,42,816 | 1,40,676 | 1,36,951 | 1,44,761 | 1,40,577 | 1,41,909 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Shanghvi Finance Private Limited | Promoter | 42.25% | 0.00 |
| Dilip.S.Shanghvi | Promoter | 19.09% | 0.00 |
| Sun Pharmaceutical Industries Key Employees Benefit Trust | Public | 3.16% | 0.00 |
| Lakshdeep Investments & Finance (P) Ltd. | Public | 1.85% | 0.00 |
| Aditya Medisales Limited | Promoter | 1.50% | 0.00 |
| Raksha Sudhir Valia | Promoter | 1.27% | 0.00 |
| Vijay Mohanlal Parekh | Public | 1.14% | New |
| Paresh Mohanlal Parekh | Public | 1.12% | New |
| Enam Securities Private Limited | Public | 1.05% | 0.00 |
| Sudhir Vrundavandas Valia | Promoter | 0.57% | 0.00 |
| Unimed Investments Limited | Promoter | 0.39% | 0.00 |
| Vibha Dilip Shanghvi | Promoter | 0.33% | 0.00 |
| Aalok Dilip Shanghvi | Promoter | 0.11% | 0.00 |
| Vidhi Dilip Shanghvi | Promoter | 0.11% | 0.00 |
| Shanghvi Family & Friends Benefit Trust | Promoter | 0.05% | 0.00 |
| Kumud Shantilal Shanghvi | Promoter | 0.01% | 0.00 |
| Psl Limited | Public | Exited | — |
Promoters held 65.74% of Sun Pharma Advanced Research Company at the end of the Jun 2026 quarter, up 0.01 percentage points from 65.73% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 3.93% (up 1.87 percentage points from 2.06% a quarter earlier) and domestic institutions (DIIs) held 0.09% (down 0.78 percentage points from 0.87% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Sun Pharma Advanced Research Company had 1,41,909 shareholders at the end of the Jun 2026 quarter, against 1,40,676 a year earlier.
Sun Pharmaceutical Industries Key Employees Benefit Trust (Public) held 3.16% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.